American Renal Associates (ARA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Sales | 186,299 | 178,274 | 187,711 | 185,992 | 177,025 |
| Cost of Goods | 134,077 | 125,142 | 119,599 | 118,059 | 120,301 |
| Gross Profit | 52,222 | 53,132 | 68,112 | 67,933 | 56,724 |
| Operating Expenses | 39,726 | 35,593 | 35,810 | 40,836 | 44,555 |
| Operating Income | 12,573 | 17,681 | 32,901 | 27,156 | 12,470 |
| Interest Expense | 7,457 | 7,257 | 7,255 | 7,188 | 7,609 |
| Other Income | -1,021 | 1,773 | 3,585 | -3,167 | 4,517 |
| Pre-tax Income | 4,095 | 12,197 | 29,231 | 16,801 | 9,378 |
| Income Tax | -3,069 | 10,026 | 2,559 | 410 | -3,524 |
| Net Income Continuous | 7,164 | 2,171 | 26,672 | 16,391 | 12,902 |
| Minority Interests | 10,966 | 11,394 | 18,689 | 18,497 | 14,153 |
| Net Income | $-3,802 | $-9,223 | $7,983 | $-2,106 | $-1,251 |
| EPS Basic Total Ops | -0.10 | -0.23 | 0.26 | -0.15 | -0.40 |
| EPS Basic Continuous Ops | 0.23 | 0.07 | 0.86 | 0.53 | 0.42 |
| EPS Diluted Total Ops | -0.10 | -0.21 | 0.24 | -0.15 | -0.40 |
| EPS Diluted Continuous Ops | 0.23 | 0.14 | 0.79 | 0.53 | 0.42 |
| EBITDA(a) | $22,693 | $27,918 | $42,808 | $37,073 | $22,074 |